Starpharma Holdings Ltd - Company Profile
Powered by
All the data and insights you need on Starpharma Holdings Ltd in one report.
- Save hours of research time and resources with
our up-to-date Starpharma Holdings Ltd Strategy Report
- Understand Starpharma Holdings Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s development programs include its DEP drug delivery, which is built around dendrimers and VivaGel portfolio. Its flagship product candidate, VivaGel, is a gel-based formulation for the treatment and prevention of bacterial vaginosis (BV) and it is also used as a vaginal microbicide to prevent the sexually transmitted infections including HIV and genital herpes. It has license arrangements with several partners including Okamoto Industries and AstraZeneca among others. The company has research facilities in Melbourne, Australia. Starpharma is headquartered in Abbotsford, Victoria, Australia
Starpharma Holdings Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Gel | VivaGel |
Condoms | DEP |
Nasal Spray | Viraleze |
Competitor Comparison
Key Parameters | Starpharma Holdings Ltd | Rhinomed Ltd | ResApp Health Ltd | Immuron Ltd | GLYDE Health Pty Ltd |
---|---|---|---|---|---|
Headquarters | Australia | Australia | Australia | Australia | Australia |
City | Melbourne | Richmond | Brisbane | Carlton | Lindfield |
State/Province | Victoria | Victoria | Queensland | Victoria | New South Wales |
No. of Employees | 50 | - | 3 | 6 | - |
Entity Type | Public | Private | Private | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Rob Thomas | Chairman | Executive Board | 2014 | - |
Jacinth K Fairley | Director; Chief Executive Officer | Executive Board | 2006 | - |
Justin Cahill | Company Secretary; Chief Financial Officer | Senior Management | 2023 | - |
Jeremy Paull | Vice President - Development and Regulatory Affairs | Senior Management | - | - |
Tony Eglezos | Vice President - Business Development | Senior Management | 2013 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer